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Tenascin-C (TN) is a large hexameric glycoprotein found in the
extracellular matrix (Erickson and Bourden, 1989; Chiquet-
Ehrismann, 1993). It is thought to be involved in numerous
cellular functions including adhesion, migration, embryonic devel-
opment, wound healing and tumour metastasis (Erickson and
Bourden, 1989; Chiquet-Ehrismann, 1993). It is strongly
expressed in developing fetal tissues, while in normal adult tissues
and organs its expression is generally limited to areas associated
with proliferation and cellular re-organization. In many solid
tumours, TN is overexpressed in the stroma and this led to the
suggestion that it may be associated with malignant invasion
(Mackie et al, 1987). Several forms of TN protein are generated by
alternative splicing of one common primary transcript (Chiquet-
Ehrismann, 1993) and we have previously identified multiple
RNA transcripts in malignant ovarian tumours (Wilson et al,
1996). We have also demonstrated that TN is overexpressed in the
stroma of malignant ovarian tumours at a significantly greater
incidence and intensity than found in benign ovarian tumours
(Wilson et al, 1996). The highest level of expression is observed at
epithelial–mesenchymal junctions, leading us to speculate on the
cellular source of TN, and the presence of paracrine regulation of
TN secretion (Wilson et al, 1996). The transient and dynamic
occurrence of TN in normal cellular systems has led to suggestions
of it being regulated by growth factors and cytokines and several
inducers, most notably transforming growth factor (TGF)-b, have
been identified (Pearson et al, 1988; Rettig et al, 1994).
In this study we have investigated the production of TN in
epithelial and stromal ovarian cell lines to determine the primary
cell type producing TN and have used a co-culture system to iden-
tify whether paracrine influences might be involved in its regula-
tion. The effects on TN regulation of specific growth factors,
cytokines and hormones which are likely to be present in vivo
were then investigated. Finally evidence for a functional role in
invasion was sought by the use of adhesion and migration assays
and the expression of several integrins known to bind TN was
examined.
MATERIALS AND METHODS
Cell lines
The human ovarian carcinoma cell lines PE01, PE04 and PE01CDDP
were established and characterized as previously described
(Langdon et al, 1988). The SKOV-3 and 59M ovarian carcinoma
cell lines were obtained from the European Collection of Animal
Cell Cultures, Porton Down, UK. All these lines were routinely
cultured at 37°C in an atmosphere of 5% carbon dioxide/95% air
in Dulbecco’s modified Eagle medium (DMEM) containing
phenol red indicator. The medium was supplemented with 10%
fetal calf serum (FCS), 2 mML -glutamine, 100 IU ml–1 penicillin
and 100 mg ml–1 streptomycin.
The fibroblast cell lines PE012F, PE027F, PE09F and PE013F
were initiated from ascitic cells obtained from patients with
primary ovarian cancer. Ascitic cells which had been washed in
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Correspondence to: SP LangdonDMEM + 10% FCS were placed into 25-cm2 flasks and allowed to
adhere. The fibroblast cells were selected on the basis of their
rapid attachment to tissue culture plastics. Fibroblasts attached to
the plastic substrate more rapidly than epithelial cells and media
containing unattached cells were poured off after 2–4 h, leaving a
predominantly fibroblastic population.
The original ascites preparations contained a high percentage of
leucocytes and epithelial cells with a minority (approximately
10%) of fibroblasts. After the above culture selection, the final
populations of fibroblasts were found to be > 99% pure with less
than 1% contamination by leucocytes or tumour cells as indicated
by immunocytochemistry.
Immunocytochemistry
Once the cultures were established, after 1–2 passages, multispot
slides were prepared and immunocytochemistry was used to
compare the samples of the fibroblast cultures with the original
ascites population. Cells were incubated with either 5B5 mouse
anti-human fibroblast monoclonal antibody (used at 1:100; Dako,
Ely, UK), 2B11 mouse anti-human leucocyte common antigen
(used at 1:10; Dako, Ely, UK), E29 mouse anti-human epithelial
membrane antigen (used at 1:40; Dako, Ely, UK) or Tris-buffered
saline (TBS: as control) for 30 min at room temperature. After
washing in TBS, multispots were treated with rabbit anti-mouse
biotinylated antibody diluted 1:100 in TBS, followed by
avidin–biotin peroxidase complex made up in TBS; both incuba-
tions being for 30 min at room temperature and followed by
washing in TBS. After the final wash, multispots were treated with
a solution of 3,3¢-diaminobenzidine (1 mg ml–1) containing 5%
hydrogen peroxide for 5 min. Multispots were then dehydrated,
cleared and mounted under coverslips with DPX mounting
medium.
Preparation of cells for measurement of TN secretion
Cells were plated onto tissue culture flasks or trays at high density
(70–90% confluence) in DMEM (+ 10% FCS). The serum-
containing medium was then removed and the cells were washed
in phosphate-buffered saline (PBS) before the addition of serum-
free medium, phenol red-free DMEM containing HITS (10 nM
hydrocortisone, 5 mg ml–1 insulin, 10 mg ml–1 transferrin and 30 nM
sodium selenite). After a wash-out period (~12 h), fresh media
were added and the cells were incubated for 48 h. After this time,
the conditioned medium (CM) was collected and centrifuged in
polypropylene tubes at 2000 rpm to remove dead cells and other
debris. The cells were then harvested and counted. CM was imme-
diately plated out for an enzyme-linked immunosorbent assay
(ELISA) as described below.
To assess the effects of growth factors, hormones and cytokines
on TN secretion, concentrations were selected which had previ-
ously been determined to produce effects on growth in ovarian
systems. These factors were added to the cells in a total volume of
500 ml of medium. The cells were incubated for 48 h, counted and
the medium assayed for TN content by ELISA as described below.
ELISA
Some 96-well plastic plates (Immulon 4) were coated overnight
with purified TN (Gibco BRL, Paisley, UK) diluted in PBS
(200 ml) to give a range of 0.5–16 ng TN per well for a standard
curve. Each sample of CM (200 ml), was also added to wells for
overnight incubation. CM was assessed neat and diluted 1:2 with
PBS. Following the overnight incubation the plates were thor-
oughly washed with PBS containing 0.5% Tween-20 (PBS-T).
Half the plate was then incubated for 2 h at 37°C with monoclonal
mouse anti-human TN antibody (Dako, Ely, UK) at a 1:160 dilu-
tion in PBS-T while the remaining half was left in PBS-T as a
measure of background binding. The plates were washed and incu-
bated with rabbit anti-mouse Ig diluted 1:1000 in PBS-T for 1 h at
37°C before a final washing in PBS-T. A total of 50 mg of
orthophenylenediamine (OPD) were dissolved in 100 ml of
substrate buffer (0.71 g anhydrous Na2HPO4, 0.5 g citric acid,
pH 5.0). Immediately prior to use, 20 ml of hydrogen peroxide
were added. OPD solution (200 ml) was added to each well and the
plate was incubated for 10 min at room temperature in the dark.
The reaction was terminated by addition of 50 ml of 0.5 M
sulphuric acid and the optical density of each well was measured
on a spectrophotometer at a wavelength of 492 nm.
A 1:2 dilution was also routinely assayed for all samples and
these were shown to dilute in similar fashion to TN standards
giving an absorbance value half that of neat samples. The numbers
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Table 1 Co-expression of TN and TGF-b in a series of malignant ovarian
tumours
Sample TN protein TGF-b–RNA isoform expression
TGF-b1 TGF-b2 TGF-b3
002 +++a +b ++
006 – + – +
008 + + – +
014 ++ + + +
015 + – – +
019 +++ + – –
020 – – + –
021 ++ + + –
069 +++ + + +
072 ++ + + –
077 ++ + + +
095 +++ – + –
096 – – + –
104 – – + +
109 + – + +
117 + + + –
122 ++ + + –
124 ++ + + +
132 +++ + + +
134 – + – –
137 + – + –
148 + – – –
149 ++ – + –
aTN protein: – = negative; + = weak staining; ++ = moderate staining; +++ =
strong staining. bTGF-b RNA isoform: + = positive; – = negative.
Table 2 Percentage migration of ovarian cancer cell lines through TN and
FN
Migration (%)
Cell line BSA control TN FN
SKOV-3 2.8 (0.3a) 19.2 (4.9) 25.3 (2.1)
PE01 3.5 (1.3) 8.1 (0.9) 5.0 (0.2)
aThe percentage of cells migrating through the ECM matrix in a 48 h period
is shown. Each value is the mean ± standard deviation of triplicate wells.
TN = tenascin-C;FN = fibronectin; BSA = bovine serum albumin.of cells secreting TN into the media were counted and the measure-
ments of TN secretion were corrected for cell number. Within each
assay duplicate samples were measured and the secretion of TN
was expressed as the ng produced in the 48-h incubation period per
million cells per ml of media (ng of TN per 106 cells ml–1 per 48 h).
Each cell line was assayed on a minimum of two separate occasions
and the mean secretion of TN was calculated.
Co-culture experiments
Tissue culture inserts with 8-mm-diameter pores were used to co-
culture fibroblast and epithelial cells. Fibroblasts (2 ´ 105) were
added to the well and a similar number of PE01 epithelial cells
were added to the inserts (in a separate tray). The cells were
allowed to attach for 24 h in DMEM (+10% FCS) and incubated
overnight in DMEM (+ HITS). After this time the inserts were
moved to the tray containing the fibroblasts. Fresh serum-free
medium was added to the well and the insert (500 ml and 300 ml
respectively). The cells were incubated for 48 h at 37°C and
counted; the media were collected and assayed for TN content by
ELISA.
Cell adhesion assay
Non-sterile 96-well trays were coated overnight at 4°C (or for 2 h
at 37°C) with the extracellular matrix proteins (10 mg ml–1) TN,
fibronectin (Sigma, Poole, UK) or collagen IV (Sigma, Poole, UK)
in quadruplicate wells. To take into account non-specific binding
to protein 1% bovine serum albumin (BSA) solution (in PBS) was
used as a control. After coating, the plates were washed in PBS.
Non-specific adherence to plastic was blocked by incubation for
90 min in 0.1% BSA solution. Cells were harvested in a small
amount of trypsin to produce a single cell population, and labelled
with chromium (51Cr) as described by Brunner et al (1976). The
cells were washed three times in serum-free media to remove
traces of extracellular matrix (ECM) proteins and serum, and
resuspended to produce a concentration of 3 ´ 105 per ml. Aliquots
(50 ml) of the suspension were added to each well and to counting
tubes as the ‘input’ count. After incubation at 37°C for 2 h, plates
were washed twice by gently submerging the plate in PBS supple-
mented by cations (1 mM Ca2+/0.5 mM Mg2+). Plates were then cut
into individual wells and counted in a g-counter.
Cell migration assay
Migration assays were performed in 8-mM-diameter pore size
Transwell chambers in a method adapted from Mould et al (1994).
The undersurface of the polycarbonate membrane was coated with
ECM proteins by placing the insert into the relevant protein solu-
tion (TN, fibronectin or BSA; 10 mg ml–1) for 1 h at 37°C. The
protein solution was removed and the membranes were washed in
PBS. Cells were harvested to produce a single-cell suspension of
4 ´ 105 cells ml-1 in serum-free DMEM containing 1% BSA.
Aliquots of the cell suspension (1 ´ 105) were added to the upper
chamber of the Transwell and 500 ml of the same media were
added to the lower chamber. The cells were incubated at 37°C for
48 h in a humidified incubator and cells allowed to migrate. Cells
were then harvested by trypsinization and migration was expressed
as the percentage of cells that had passed through the membrane.
Analysis of integrin expression by flow cytometry
Cells were harvested using trypsin–EDTA which was immediately
neutralized with DMEM containing 10% FCS. Cells were then
collected after centrifugation at 2000 rpm for 5 min and resus-
pended in complete medium at 1 ´ 106 cells ml–1 and kept in an
incubator at 37°C for 30 min before staining. For each cell line, 3
aliquots of 5 ´ 105 cells were incubated with each primary anti-
body. The following monoclonal antibodies were used: JB1 (anti-
b1 integrin; Chemicon, Harrow, UK), P1E6 (anti-a2b1; Dako,
Ely, UK), P1B5 (anti-a3b1; Dako, Ely, UK), LM609 (anti-avb3;
Chemicon, Harrow, UK) and anti-annexin II (Affiniti, Mamhead,
UK). The aliquots were washed once in ice-cold PBS, then in PBS
containing 5% FCS before addition of 100 ml of diluted antibody
(1:50 for JB1 and LM609; 1:40 for P1E6 and P1B5 and 1:20 for
annexin II) to each tube. Negative controls had 100 ml PBS–FCS
added. The tubes were incubated on ice for 60 min, then washed
once in PBS–FCS. Rabbit anti-mouse immunoglobulin RPE
conjugate (100 ml) was added to each tube and incubated on ice for
60 min. The cells were again washed in PBS–FCS and re-
suspended in 1 ml PBS for analysis on a FACScan flow cytometer
using the Lysys II program.
RESULTS
Secretion of TN by ovarian cell lines
To identify the major ovarian cell type (fibroblast or epithelial)
producing TN, conditioned media were collected from ovarian
fibroblast and ovarian carcinoma cell lines cultured under serum-
free conditions for 48 h and assayed by ELISA. The concentra-
tions of TN in media from the fibroblast cell lines PE09F, PEO12F,
PE013F and PE027F ranged from 519 to 1053 ng TN 10–6 cells
ml–1 per 48 h (Figure 1). In contrast, the concentrations in the
media from the ovarian carcinoma cell lines were < 1% of the
fibroblast levels with SKOV-3 and 59M producing approximately
4 ng 10–6 cells ml–1 per 48 h, while media from the remaining three
carcinoma cell lines PE01, PE04 and PE01CDDP did not contain
measurable TN (< 2 ng 10–6 cells ml–1 per 48 h).
Tenascin-C in ovarian cancer cell lines 687
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Figure 1 Levels of TN in media from ovarian fibroblast and carcinoma cell
lines. PE012F, PE027F, PE09F and PE013F are fibroblast lines and PE01,
PE04, PE01CDDP, SKOV-3 and 59M are carcinoma lines. Mean values
standard error from a typical assay are shown. Cells were incubated in
serum-free medium for 48 h and TN content was measured by ELISA as
described in Materials and MethodsModulation of TN secretion
Observations of primary tumours suggested that the strongest
expression of TN was at junctions between carcinoma cells and
stroma, implying possible paracrine regulation. In order to investi-
gate this in a tissue culture model, ovarian fibroblasts (PE012F or
PE09F) were co-cultured with the PE01 ovarian carcinoma cell
line. The fibroblast and epithelial cell populations were kept sepa-
rate using porous tissue culture inserts with the fibroblasts being
placed at the bottom of the well and PE01 carcinoma cells being
grown in the insert.
Media were collected from the cells after 48 h of co-culture and
assayed for TN content by ELISA. PE01 cells generated a level of
< 2 ng TN 10–6 cells ml–1 per 48 h, while PE012F and PE09F cells
produced concentrations of 342 and 98 ng TN 10–6 cells ml–1 per
48 h, respectively, when the lines were grown in the absence of the
other cell type. When the fibroblasts were co-cultured with the
PE01 cells, the level of TN measured increased to 432 and 131 ng
TN 10–6 cells ml–1 per 48 h for the PE012F–PE01 and PE09F–PE01
co-cultures respectively. Repetition of this experiment indicated a
small, but consistent, 20–30% increase in TN secretion by co-
culture. This increase in TN secretion was observed on 11 of 12
occasions (P = 0.0034, Wilcoxon signed rank test).
Effects of growth factors, hormones and cytokines on
TN secretion
The effects of specific growth factors, hormones and cytokines as
regulators of TN expression were investigated as these might
mediate the paracrine interaction between fibroblast and epithelial
cells. The agents examined were chosen on the basis of their modula-
tion of TN secretion in other cell types and also on their effects on
ovarian cell behaviour. The concentrations used for the initial
screening had previously been established to produce growth effects
in ovarian cancer cells. All these factors were tested for cross-reac-
tivity in the ELISA and found to be negative. Figure 2 illustrates the
modulation of TN secretion in the PE012F ovarian fibroblast cell line
by this range of factors. TN secretion in the PE012F ovarian fibrob-
last cell line was markedly stimulated by TGF-b1 (2.4 nM). While
insulin-like growth factor (IGF)-II (10 nM) and progesterone (0.1 nM)
did not produce a large increase, they consistently stimulated TN
secretion above control levels. Conversely, TN secretion was
inhibited by the gonadotropins, human choriogonadotropin (hCG;
10 IU ml–1) and follicle-stimulating hormone (FSH; 0.1 IU ml–1) and
also  g-interferon (10 IU ml–1). HCG produced the greatest effect
decreasing TN secretion to approximately 50% of control levels.
17b-Oestradiol (0.1 nM), IGF-I (10 nM) and endothelin-1 (10 nM)
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Figure 2 Modulation of TN concentration in media conditioned by the
PE012F fibroblast cell line after exposure to hormones, growth factors and
cytokines. These data represent the mean values of TN secretion from
triplicate wells with error bars representing standard deviation. The
concentrations used were as follows: E2 (17-b-oestradiol), 0.1 nM; hCG
(human choriogonadotropin), 10 IU ml–1; FSH (follicle-stimulating hormone),
0.1 IU ml–1; IGF-I (insulin-like growth factor I), 10 nM; IGF-II (insulin-like
growth factor II), 10 nM; IFN (interferon-g), 10 IU ml–1; TGF-b (transforming
growth factor b1), 2.4 nM; PG (progesterone), 0.1 nM; ET-1 (endothelin-1),
10 nM. Cells were incubated in serum-free medium containing the above
factors for 48 h and TN content was measured by ELISA as described in
Materials and Methods. *P < 0.05 significantly different from the control
(Student’s t-test)
Figure 4 Attachment of SKOV-3 ovarian cancer cells to varying
concentrations of ECM proteins. These data represent the percentage of
cells binding to collagen IV (CIV), fibronectin (FN) and tenascin (TN) after
2 h. Data shown represent mean values from quadruplicate wells. Error bars
are not shown, but were always < 10% of the mean values
Figure 3 Modulation of TN concentration in media conditioned by the
PE012F fibroblast cell line after exposure to varying concentrations of TGF-
b1 (transforming growth factor b1). The values shown are mean values from
quadruplicate wells and error bars represent standard deviations. Cells were
incubated in serum-free medium containing TGF-b1 for 48 h and TN content
was measured by ELISA as described in Materials and Methods
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)had no effect on TN secretion. TGF-b1 produced the largest stimula-
tion of TN secretion of all the factors tested. To investigate whether
TGF-b1 exerted its effects in a dose-dependent manner the factor was
added in a range of concentrations, as used by Pearson et al (1988).
Figure 3 illustrates the modulation of TN secretion in PE012F fibro-
blasts by TGF-b1. All concentrations tested between 5 and 60 ng ml–1
enhanced TN secretion, with maximum secretion being observed at
10 ng ml–1.
Tenascin expression and TGF-b isoform expression in
primary ovarian tumours
To examine the association between TN and TGF-b expression
further, the incidence of co-expression was explored in a series of
23 primary ovarian tumours. TN expression had previously been
reported in a cohort of ovarian carcinomas (Wilson et al, 1996)
and, in a separate study, the presence of different TGF-b isoforms
had been defined (Bartlett et al, 1997). The expression of both TN
and TGF-b isoforms is shown in Table 1. Of the 23 tumours exam-
ined, 14 expressed TGF-b1 mRNA, 17 expressed TGF-b2 mRNA
and 13 expressed TGF-b3 mRNA. If tumours are divided into
those expressing moderate–strong levels of TN are compared with
those expressing weak–no staining then analyses using Fischer’s
exact test indicated a significant relationship (P = 0.036) between
TGF-b1 expression and TN, but not between TGF-b2 or TGF-b3
and TN (P = 0.069 and 1.00 respectively).
Effect of TN on ovarian cancer cell adhesion and
migration
The adhesion of the ovarian carcinoma cell lines to TN, fibronectin
and collagen IV was investigated. BSA (1%) was used as a control
to examine any non-specific protein binding; the binding to BSA
was always less than 10% of the input value. An initial experiment
using the SKOV-3 cell line determined the optimal concentration
of ECM protein. For all three ECM proteins, 10 mg ml–1 produced
maximum or near maximum binding and was therefore selected
for subsequent experiments (Figure 4). While concentrations of 20
and 40 mg ml–1 produced effects similar to that obtained at 10 mg
ml–1 for both collagen IV and fibronectin, the adhesion for TN
showed a biphasic pattern (Figure 4).
The adhesion of the 59M, PE01 and PE04 cell lines to the ECM
proteins (in addition to the SKOV-3 cell line) are shown in Figure
5. The SKOV-3 and 59M cell lines show comparable levels of
adhesion to each other; in the wells containing fibronectin and
collagen IV, 30–40% of the cells attached within 2 h. In the wells
containing TN, attachment was approximately 10% of the input
value. The PE01 cell line showed a different preference for the
ECM proteins. The greatest level of adhesion (29%) was observed
on fibronectin with only a slightly reduced level of binding to TN
(22%). The poorest substrate for adherence of PE01 cells was
collagen IV, which demonstrated only 11% adhesion. PE04 cells,
overall, demonstrated the lowest levels of adhesion, with
maximum levels of 14% seen on collagen IV, 10% binding for TN
and the least preference for fibronectin (6%). All these values were
corrected for non-specific protein binding by subtracting the level
of adhesion to the wells containing BSA. Therefore, it can be seen
from these data that TN does promote the attachment of ovarian
carcinoma cells; however, different cell lines have varying affini-
ties for the ECM proteins studied.
The migration of SKOV-3 and PE01 cells through TN was
compared with migration through BSA and fibronectin. Cells were
allowed to migrate for 48 h through a porous transwell insert
whose underside was coated with each respective protein and
migration assessed as the percentage of cells passing through the
membrane (Table 2). For SKOV-3 cells, while only 2.8% of cells
migrated through BSA, 19.2% migrated through TN and 25.3%
through fibronectin indicating that both proteins promote migra-
tion of this cell line. For PE01 cells, migration was only slightly
increased in tenascin (8.1% migration) and even less so in
fibronectin (5% migration) compared to the BSA control (3.5%
migration) (Table 2).
Integrin profiles of the cell lines
The expression of several integrins that are known to bind TN was
investigated. b1 receptors were identified in the 59M, SKOV-3,
PE01 and PE04 cell lines and specific antibodies for the a2b1 and
a3b1 integrins indicated expression of both integrins in all four cell
lines (Figure 6). The avb3 integrin was found at low levels in the
59M and SKOV-3 lines but not in the PE01 or PE04 lines (Figure
6). Cell surface annexin-II expression was not detected in any of
these lines.
DISCUSSION
In the present study, measurement of TN by ELISA demonstrated
that media from ovarian fibroblasts contained TN at levels approx-
imately 100-fold higher than from ovarian carcinoma cell lines.
This is consistent with the strong stromal staining of TN found in
primary ovarian carcinoma sections and suggests that fibroblasts
are likely to be the primary source of TN. Several other studies
have demonstrated that fibroblasts are capable of producing TN
and the levels in this study are comparable with levels reported
for non-ovarian fibroblasts (Erickson and Bourd0n, 1989). The
ovarian carcinoma cell lines SKOV-3 and 59M also produced
low levels of TN and these are the first data reported for ovarian
carcinoma lines.
Tenascin-C in ovarian cancer cell lines 689
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Figure 5 Attachment of ovarian cancer cells to different ECM proteins. The
percentage attachment after 2 h is recorded and values shown are mean
values from quadruplicate wells and the error bars represent standard
deviation. The ECM proteins (TN = tenascin; FN = fibronectin; CIV = collagen
IV) were used at a concentration of 10 mg ml–1
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)In a previous study (Wilson et al, 1996) we observed that TN was
not only overexpressed in the stroma of primary ovarian cancers but
this expression was most intense at the interface between carcinoma
cells and stroma suggestive of paracrine regulation. Co-culture of
ovarian fibroblasts with ovarian carcinoma cells led to an increased
secretion of TN and this would be consistent with observations for
breast cancer wherein media conditioned by MCF-7 breast carci-
noma cells induced fibroblasts to synthesize TN (Chiquet-
Ehrismann et al, 1989). In this latter study, the inducer within the
conditioned medium was shown to be TGF-b1. Because of this we
have studied the effects of TGF-b and a number of important
ovarian regulators and products for their ability to modulate TN
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Figure 6 Integrin expression in ovarian carcinoma cell lines. Cells were incubated with anti-integrin antibodies for 60 min on ice and then incubated with rabbit
anti-mouse immunoglobulin RPE conjugate for 60 min. Cells were then analysed on a FACScan flow cytometer. Values are expressed as fluorescence intensity
against number of events. The following monoclonal antibodies were used: JB1 (anti-b1 integrin), P1E6 (anti-a2b1), P1B5 (anti-a3b1) and LM609 (anti-avb3). The
background profile refers to the fluorescence produced in the absence of primary antibody. The profile for annexin-II was identical to that of the backgroundsecretion. Of these, TGF-b1 proved to be the strongest inducer in our
ovarian fibroblast model. Further support that this peptide growth
factor may be an important regulator of TN in ovarian cancer was
obtained from an analysis of primary ovarian carcinoma sections,
which indicated that TN expression was significantly associated
with TGF-b1 expression. A similar association has been reported in
invasive breast carcinoma (Walker et al, 1994) and in the tissue
distribution in mouse embryos (Pearson et al, 1988).
While TGF-b appears to be an important, and perhaps even
principal, regulator of TN, there are data to indicate that a number
of other extrinsic factors may also contribute jointly to the regula-
tion of TN secretion in a modular fashion (Rettig et al, 1994).
These include epithelial growth factor (EGF), fibroblast growth
factor (FGF), interleukin (IL)-1, IL-4, tumour necrosis factor
(TNF)-a, platelet derived growth factor (PDGF), steroid
hormones, glucocorticoids and angiotensin II. Of the agents inves-
tigated that have important roles in normal ovarian physiology,
progesterone and IGF-II produced small but consistent stimula-
tions, while the gonodotrophins FSH and hCG (which produces
the same biological responses as luteinizing hormone) and g-inter-
feron decreased TN secretion. It seems likely that in vivo, these
separate processes may well be integrated to produce a final
response. In addition to these soluble factors, it is also likely that
cell–cell contacts will be important in regulating secretion of TN.
During malignant invasion and metastasis the processes of both
adhesion and anti-adhesion are important. TN has been shown to
contain both adhesive (within its alternatively spliced region) and
anti-adhesive elements (within the EGF-like repeat structures)
(Spring et al, 1989). In the present study, TN enhanced the adhesion
of all four ovarian carcinoma cell lines examined compared to the
BSA control and this may be important in promoting attachment to
the basement membrane prior to proteolysis and facilitating migra-
tion through the ECM. These cell lines also adhere as well, if not
better, to fibronectin and an alternative mode of action of TN is in
its competition with fibronectin for cell binding thereby inhibiting
integrin-mediated attachment of cells to fibronectin and allowing
cell movement to take place (Chiquet-Ehrismann et al, 1988).
Furthermore, TN can physically bind to fibronectin and sterically
blocking cell access to the matrix (Chiquet-Ehrismann et al, 1988).
An intriguing observation using a glioma model has recently
reported wherein TN was found to provide a positive effect on
fibronectin-mediated migration by altering cell morphology and
enhancing cell motility (Deryugina and Bourdon, 1996).
A biphasic effect similar to that observed for SKOV-3 cells
binding to TN has been previously observed for glioma cell
attachment by Giese et al (1996). These investigators observed
maximum binding of glioma cells at 10 mg ml–1 but decreased
binding at 33 and 100 mg ml–1. Based on this observation together
with data from migration and integrin analysis studies, they
concluded that glioma cells express two separate receptors which
allow these opposing effects to occur at different densities of TN;
such a view might explain these observations in SKOV-3 cells.
TN also promoted the migration of the SKOV-3 and PE01 cell
lines. This promotion of migration may allow ovarian carcinoma
cells to invade more readily into surrounding stroma. In other
systems TN can both promote (Deryugina and Bourdon, 1996) or
inhibit (Hoffman et al, 1994) cellular migration.
TN is known to bind to several integrins on the cell surface,
including a2b1, a8b1, a9b1, avb3, avb6 and annexin-II (Yokasaki
and Sheppard, 1995; Chung and Erickson, 1994). Antibodies to
several of these molecules were available, and b1 and specifically
a2b1 and a3b1 expression were found in all four cell lines exam-
ined. avb3 was expressed in two of the four lines, while annexin-II
was not detected in any of these lines. Cell adhesion to TN in
several normal and malignant cell types has previously been
shown to involve at least two sites, the SRRGDMS site which
binds avb3 and  avb6, and a non-RGD site which binds a2b1
(Deryugina and Bourdon, 1996). The a2b1 site has been proposed
to play a more important role in TN cell migration (Deryugina and
Bourdon, 1996). The avb3 integrin is involved in the migration of
fibronectin and the higher expression of avb3 and lower expression
of a2b1 in SKOV-3 cells compared to PE01 cells may contribute to
the more rapid migration of SKOV-3 cells through fibronectin than
TN while PE01 cells migrate more rapidly through TN than
fibronectin.
In conclusion, these data indicate that in ovarian cancer systems,
TN is secreted predominantly from fibroblasts, is regulated by a
variety of factors including TGF-b and has effects on both cell
adhesion and migration suggesting a facilitating role in invasion.
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